HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Church & Dwight’s Domestic Consumer Business Grows Despite Costs In Q1

This article was originally published in The Rose Sheet

Executive Summary

Church & Dwight's new product pipeline, "impactful" marketing programs and pricing initiatives fueled revenue growth of its domestic consumer business in the fiscal 2008 first quarter, according to CEO James Craigie

You may also be interested in...



Church & Dwight’s Value Brands Provide Strength In Shaky Market

Church & Dwight's value brand segment has become a source of strength for the firm with consumers increasingly opting for product trade-downs and private-label brands, the company indicated during a second quarter analyst call Aug. 4

Church & Dwight’s Value Brands Provide Strength In Shaky Market

Church & Dwight's value brand segment has become a source of strength for the firm with consumers increasingly opting for product trade-downs and private-label brands, the company indicated during a second quarter analyst call Aug. 4

Church & Dwight Gains Orajel With $380 Million Del OTC Purchase

Church & Dwight has agreed to acquire Del Pharmaceuticals' OTC brands, including the Orajel topical analgesic line, for $380 million in cash from Coty, Inc., the firm said April 1

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015417

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel